Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 1

2(33.3%)

Phase 4

1(16.7%)

6Total

N/A(3)

Phase 1(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04637464Not ApplicableCompleted

Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer

Role: lead

NCT02912676Phase 1Completed

Thiopurine EnhAnced Maintenance Therapy

Role: lead

NCT01906671Phase 4Unknown

Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral Liquid

Role: lead

NCT02141100Phase 1Withdrawn

Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma

Role: lead

NCT01772862Not ApplicableUnknown

Rehabilitation Including Social and Physical Activity in Children and Teenagers With Cancer

Role: lead

NCT01772849Not ApplicableUnknown

Rehabilitation Including Social Activity and Education in Children and Teenagers With Cancer

Role: lead

All 6 trials loaded